Potential cancer drug patents

EiRx Therapeutics, the AIM-quoted drug discovery company based at Cork Airport Business Park, has filed patent applications for new drug candidates with potential value as treatments for a range of cancers, including colorectal and breast tumours.

Research director Finbarr Murphy said the success of the company’s technology, called EnPAD, had demonstrated its ability to identify drug candidates, which were “an important milestone” in the development of EiRx’s portfolio.